Literature DB >> 22672299

Synergic effects of levamlodipine and bisoprolol on blood pressure reduction and organ protection in spontaneously hypertensive rats.

Yan-Ling Yang1, Li-Ting Yu, Zhao-Tang Wu, Jian-Guang Yu, Jing-Ming Zhang, Qing-Hua Chen, Yong-Chu Bao, Jian-Guo Liu.   

Abstract

AIMS: Stroke is a major cause of disability and death worldwide. Hypertension is one of the most important risk factors for stroke. The objective of this work was to study the synergic effects of levamlodipine and bisoprolol on blood pressure reduction and organ protection in spontaneously hypertensive rats (SHR).
METHODS: Blood pressure was continuously monitored in conscious SHR. For acute study, a single dose of drugs was administrated via an intragastric catheter. For chronic study (4 months), drugs were delivered via rat chow.
RESULTS: A single dose of levamlodipine (from 1 mg/kg), bisoprolol (from 0.125 mg/kg), and their combinations significantly decreased blood pressure. The levamlodipine-induced tachycardia and the bisoprolol-induced bradycardia were temporized by the combination of these two drugs. Upon chronic treatment, this combination also decreased blood pressure variability and reduced organ damage.
CONCLUSION: Levamlodipine and bisoprolol produce synergic effects on blood pressure reduction and organ protection in SHR.
© 2012 Blackwell Publishing Ltd.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22672299      PMCID: PMC6493401          DOI: 10.1111/j.1755-5949.2012.00323.x

Source DB:  PubMed          Journal:  CNS Neurosci Ther        ISSN: 1755-5930            Impact factor:   5.243


  24 in total

1.  Synergism of atenolol and amlodipine on lowering and stabilizing blood pressure in spontaneously hypertensive rats.

Authors:  Li-Ping Xu; Fu-Ming Shen; He Shu; Chao-Yu Miao; Yúan-Ying Jiang; Ding-Feng Su
Journal:  Fundam Clin Pharmacol       Date:  2004-02       Impact factor: 2.748

Review 2.  Hypertensive therapy: Part I.

Authors:  Veronica Franco; Suzanne Oparil; Oscar A Carretero
Journal:  Circulation       Date:  2004-06-22       Impact factor: 29.690

Review 3.  Hypertensive therapy: Part II.

Authors:  Veronica Franco; Suzanne Oparil; Oscar A Carretero
Journal:  Circulation       Date:  2004-06-29       Impact factor: 29.690

4.  New guidelines on hypertension.

Authors:  J M Cruickshank
Journal:  Lancet       Date:  2006-08-19       Impact factor: 79.321

5.  Blood pressure variability is more important than blood pressure level in determination of end-organ damage in rats.

Authors:  Chao-Yu Miao; He-Hui Xie; Lin-Shu Zhan; Ding-Feng Su
Journal:  J Hypertens       Date:  2006-06       Impact factor: 4.844

Review 6.  Treatment of hypertension based on measurement of blood pressure variability: lessons from animal studies.

Authors:  Ding-Feng Su
Journal:  Curr Opin Cardiol       Date:  2006-09       Impact factor: 2.161

7.  Synergism of atenolol and nitrendipine on hemodynamic amelioration and organ protection in hypertensive rats.

Authors:  He-Hui Xie; Chao-Yu Miao; Yuan-Ying Jiang; Ding-Feng Su
Journal:  J Hypertens       Date:  2005-01       Impact factor: 4.844

Review 8.  New horizons for stroke prevention: PROGRESS and HOPE.

Authors:  Philip B Gorelick
Journal:  Lancet Neurol       Date:  2002-07       Impact factor: 44.182

9.  Two useful methods for evaluating antihypertensive drugs in conscious freely moving rats.

Authors:  Ding-feng Su; Li-ping Xu; Chao-yu Miao; He-hui Xie; Fu-ming Shen; Yuan-ying Jiang
Journal:  Acta Pharmacol Sin       Date:  2004-02       Impact factor: 6.150

10.  The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report.

Authors:  Aram V Chobanian; George L Bakris; Henry R Black; William C Cushman; Lee A Green; Joseph L Izzo; Daniel W Jones; Barry J Materson; Suzanne Oparil; Jackson T Wright; Edward J Roccella
Journal:  JAMA       Date:  2003-05-14       Impact factor: 56.272

View more
  2 in total

1.  Ketanserin improves cardiac performance after myocardial infarction in spontaneously hypertensive rats partially through restoration of baroreflex function.

Authors:  Jian-guang Yu; En-hui Zhang; Ai-jun Liu; Jian-guo Liu; Guo-jun Cai; Ding-feng Su
Journal:  Acta Pharmacol Sin       Date:  2013-11-18       Impact factor: 6.150

2.  Effect of low-dose Levamlodipine Besylate in the treatment of vascular dementia.

Authors:  Kai-Xin Yao; Hang Lyu; Mei-Hua Liao; Lin Yang; Yin-Ping Gao; Qi-Bing Liu; Cheng-Kun Wang; Ying-Mei Lu; Guo-Jun Jiang; Feng Han; Ping Wang
Journal:  Sci Rep       Date:  2019-12-03       Impact factor: 4.379

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.